From Discovery to Impact — A Strategic Platform Empowering MicroSigX's Biotech Innovation
M2M® - Mind2Market® is a value creation platform designed to transform groundbreakingacademic and research excellence into real-world healthcare solutions. By integrating thescientific leadership of CU Medicine and the research infrastructure of MagIC, M2M®empowers MicroSigX to translate innovation into commercial success. This synergy acceleratesthe journey from discovery to deployment, creating measurable value across diagnostics, patientoutcomes, and global healthcare systems.
The foundation of M2M® lies in the academic leadership of Professor Siew Ng and Professor Francis Chan of the Faculty of Medicine at The Chinese University of Hong Kong. Their pioneering research in microbiome science has laid the groundwork for MicroSigX’s diagnostic platform.
Through exclusive access to proprietary microbial biomarkers and deep clinical insight, CU Medicine contributes critical scientific value that fuels innovation and ensures clinical relevance.
The Microbiota I-Center (MagIC), supported by the InnoHK initiative of the Innovation and Technology Commission of the HKSAR Government, provides the research infrastructure that powers MicroSigX’s technology. The establishment of M-Lab, a joint laboratory between MagIC and MicroSigX, enhances platform optimization and supports regulatory clinical trials.
MagIC’s contribution ensures that MicroSigX’s innovations are grounded in rigorous science and aligned with global standards for translational success.
MicroSigX leads the industry pillar of M2M® Value Creation with a clear vision — transforming healthcare through noninvasive microbiome diagnostics for early detection, better outcomes, healthier lives.
As the commercialisation engine of the M2M® platform, MicroSigX transforms academic and research excellence into scalable, real-world impact through a unified innovation pipeline. By integrating proprietary microbial biomarker panels, AI-powered analytics, and a robust diagnostic platform, MicroSigX delivers value through scientific innovation, accelerated time-to-market, and improved patient outcomes — powered by both external collaboration and its expanding internal R&D capabilities.
